HLS Therapeutics Eulerpool News

HLS Therapeutics Eulerpool News

HLS Therapeutics Notizie Azioni

HLS Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie HLS Therapeutics.

• 28 agosto ·

  Yahoo
  HLS Therapeutics to Present at H.C. Wainwright's 26th Annual Global Investment Conference
• 10 agosto ·

  Yahoo
  HLS Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
• 8 agosto ·

  Yahoo
  HLS Therapeutics Announces Q2 2024 Financial Results
• 29 luglio ·

  Yahoo
  HLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug Plan
• 25 luglio ·

  Yahoo
  HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call
• 2 luglio ·

  Yahoo
  HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust
• 8 giugno ·

  Yahoo
  HLS Therapeutics Reports Annual Meeting Results
• 5 giugno ·

  Yahoo
  Shareholders in HLS Therapeutics (TSE:HLS) are in the red if they invested three years ago
• 28 maggio ·

  Yahoo
  New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment
• 9 maggio ·

  Yahoo
  An Intrinsic Calculation For HLS Therapeutics Inc. (TSE:HLS) Suggests It's 44% Undervalued